Goldman Sachs
CNTB

Goldman Sachs’s Connect Biopharma Holdings CNTB Stock Holding History

Goldman Sachs’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.2K Buy
+29,833
New +$77.8K ﹤0.01% 6239
2022
Q4 		– Sell
-13,497
Closed -$17K – 6011
2022
Q3 		$17K Sell
13,497
-5,956
-31% -$7.16K ﹤0.01% 5961
2022
Q2 		$17K Buy
19,453
+172
+0.9% +$253 ﹤0.01% 6199
2022
Q1 		$58K Buy
19,281
+7,490
+64% +$31.6K ﹤0.01% 6237
2021
Q4 		$61K Buy
+11,791
New +$131K ﹤0.01% 6230

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Goldman Sachs's CNTB Position: Q1 2026 in Review

Goldman Sachs opened a new position in Connect Biopharma Holdings (CNTB) in Q1 2026: 29,833 shares worth $78.2K. The stake represents ﹤0.01% of the portfolio and ranks #6239 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in CNTB as recently as Q3 2022.

Goldman Sachs first reported a position in CNTB in Q4 2021 and has held it in 5 quarters since. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Goldman Sachs held 29,833 shares of Connect Biopharma Holdings worth $78.2K as of Q1 2026.
  • Connect Biopharma Holdings was a new Goldman Sachs position in Q1 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6239 holding.
  • Goldman Sachs first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 5 quarters since.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.